HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Design and rationale of the AngioSeal versus the Radial approach In acute coronary SyndromE (ARISE) trial: a randomized comparison of a vascular closure device versus the radial approach to prevent vascular access site complications in non-ST-segment elevation acute coronary syndrome patients.

AbstractBACKGROUND:
Arterial access is a major site of bleeding complications after invasive coronary procedures. Among strategies to decrease vascular complications, the radial approach is an established one. Vascular closure devices provide more comfort to patients and decrease hemostasis and need for bed rest. However, the inconsistency of data proving their safety limits their routine adoption as a strategy to prevent vascular complications, requiring evidence through adequately designed randomized trials. The aim of this study is to compare the radial versus femoral approach using a vascular closure device for the incidence of arterial puncture site vascular complications among non-ST-segment elevation acute coronary syndrome patients submitted to an early invasive strategy.
METHODS:
ARISE is a national, multicenter, non-inferiority randomized clinical trial. Two hundred patients with non-ST-segment elevation acute coronary syndrome will be randomized to either radial or femoral access using a vascular closure device. The primary outcome is the occurrence of vascular complications at an arterial puncture site 30 days after the procedure, including major bleeding, retroperitoneal hematoma, compartment syndrome, hematoma ≥ 5 cm, pseudoaneurysm, arterio-venous fistula, infection, limb ischemia, arterial occlusion, adjacent nerve injury or the need for vascular surgical repair.
RESULTS:
Enrollment was initiated in September 2012, and until October 2013 91 patients were included. The inclusion phase is expected to last until the second half of 2014.
CONCLUSIONS:
The ARISE trial will help define the role of a vascular closure device as a bleeding avoidance strategy in patients with NSTEACS.
TRIAL REGISTRATION:
ClinicalTrials.gov identifier: NCT01653587.
AuthorsPedro Beraldo de Andrade, Luiz Alberto Piva E Mattos, Marden André Tebet, Fábio Salerno Rinaldi, Vinícius Cardozo Esteves, Ederlon Ferreira Nogueira, João Ítalo Dias França, Mônica Vieira Athanazio de Andrade, Robson Alves Barbosa, André Labrunie, Alexandre Antônio Cunha Abizaid, Amanda Guerra de Moraes Rego Sousa
JournalTrials (Trials) Vol. 14 Pg. 435 (Dec 18 2013) ISSN: 1745-6215 [Electronic] England
PMID24345099 (Publication Type: Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial)
Topics
  • Acute Coronary Syndrome (diagnosis, therapy)
  • Brazil
  • Clinical Protocols
  • Equipment Design
  • Femoral Artery
  • Hemorrhage (etiology, prevention & control)
  • Hemostatic Techniques (adverse effects, instrumentation)
  • Humans
  • Myocardial Infarction (diagnosis, therapy)
  • Percutaneous Coronary Intervention (adverse effects, methods)
  • Punctures
  • Radial Artery
  • Research Design
  • Time Factors
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: